Location: New York, NY
CIK: 0001582384 · Show all filings
Period: Q2 2016 (← Previous) (Next →)
Filing Date: Dec 2, 2016
Total Value: $265M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | KITE PHARMA INC | 2,358,084 | $118M | 44.4% | $57.67 | — | COM | 49803L109 |
| CSGP | COSTAR GROUP INC | 251,837 | $55.07M | 20.8% | $16.16 | +22.4% | COM | 22160N109 |
| — | NANTKWEST INC | 4,495,495 | $27.96M | 10.5% | $11.46 | — | COM | 63016Q102 |
| SRNE | SORRENTO THERAPEUTICS INC | 2,799,790 | $15.68M | 5.9% | $12.08 | -47.1% | COM NEW | 83587F202 |
| — | HILTON WORLDWIDE HLDGS INC | 505,000 | $11.38M | 4.3% | $22.73 | — | COM | 43300A104 |
| MDXG | MIMEDX GROUP INC | 1,080,365 | $8.621M | 3.2% | $8.80 | -11.6% | COM | 602496101 |
| — | ISHARES TR | 61,073 | $6.88M | 2.6% | — | — | Call | 464287900 |
| LPLA | LPL FINL HLDGS INC | 206,647 | $4.612M | 1.7% | $43.12 | -41.8% | COM | 50212V100 |
| — | COMMUNICATIONS SALES & LEAS IN | 151,000 | $4.364M | 1.6% | $18.69 | — | COM | 20341J104 |
| — | NANTHEALTH INC | 240,648 | $3.008M | 1.1% | $12.50 | — | COM | 630104107 |
| — | ISHARES TR | 27,164 | $2.279M | 0.9% | — | — | Put | 464288953 |
| — | ISHARES TR | 13,580 | $1.552M | 0.6% | — | — | Put | 464287955 |
| EDIT | EDITAS MEDICINE INC | 59,800 | $1.459M | 0.5% | $26.29 | +28.3% | COM | 28106W103 |
| — | ISHARES TR | 4,830 | $1.243M | 0.5% | — | — | Call | 464287906 |
| — | SPDR S&P 500 ETF TR | 4,126 | $864K | 0.3% | — | — | Call | 78462F903 |
| DXJ | WISDOMTREE TR | 20,000 | $776K | 0.3% | $38.80 | — | JAPN HEDGE EQT | 97717W851 |
| TLT | ISHARES TR | 4,832 | $669K | 0.3% | $138.45 | — | 20 YR TR BD ETF | 464287432 |
| NTLA | INTELLIA THERAPEUTICS INC | 25,000 | $534K | 0.2% | $26.61 | 0.0% | COM | 45826J105 |
| — | ISHARES TR | 3,958 | $445K | 0.2% | — | — | Put | 464287950 |
| — | ADVERUM BIOTECHNOLOGIES INC | 15,000 | $47,000 | 0.0% | $3.13 | — | COM | 00773U108 |